CML to invest $20M to expand operations in Wisconsin

Cambridge Major Laboratories (CML) will spend $20 million to expand its manufacturing plant, R&D operations and administrative offices in Germantown, WI. According to the Milwaukee Business Journal, the company will get about $2 million in local and state incentives to help pay for the project, which is slated to be complete by the end of this year. With the expansion, CML intends to add 75 jobs over the next three years to the 180 it already has at its 60,000-square-foot facility in Germantown. CML was bought by American Capital ($ACAS) in a $212 million deal early last year. Story | More

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.